Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PTCT stock hub

PTC Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PTCTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PTCT

In the news

Latest news · PTCT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E37.8

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-11.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PTCT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

USD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001070081
Company name	PTC Therapeutics, Inc.
Country	United States
Country code	US
Cusip	69366J200
Employees	991
Employees Change	52%
Employees Change Percent	5.54
Enterprise value	$6.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2013-06-20
Isin	US69366J2006
Last refreshed	2026-05-10
Market cap	$6.1B
Market cap category	Mid-Cap
Price	$73.69
Price currency	USD
Rev Per Employee	834,621.59x
Sector	Healthcare
Sic	2834
Symbol	PTCT
Website	https://www.ptcbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.05%
EV Sales Forward	7.1x
EV/Sales	8.39x
FCF yield	-3.7%
Forward P/E	37.83x
P/S ratio	7.39x
PS Forward	6.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-8.11%
EBITDA Margin	-2.43%
Gross margin	37.14%
Gross Profit	$307.2M
Gross Profit Growth	-76.19%
Gross Profit Growth Q	-79.79%
Gross Profit Growth3 Y	187.92%
Net Income	$-186.7M
Net Income Growth Years	2%
Pretax Margin	-28.49%
Profit Margin	-22.58%
Profit Per Employee	$-188,423
Profitable Years	1
ROA	-1.52
Roa5y	-4.07
ROCE	-3.45
ROIC	-11.13
Roic5y	-5.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	26.38%
Cagr1y	80.86%
Cagr3y	9.7%
Cagr5y	12.86%
EPS Growth Years	2
Revenue Growth	-53.34x
Revenue Growth Q	-76.83x
Revenue Growth Years	1x
Revenue Growth3 Y	2.39x
Revenue Growth5 Y	13.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.3
Assets	$2.9B
Cash	$1.9B
Current Assets	$2.3B
Current Liabilities	$923.6M
Debt	$2.7B
Debt EBITDA	$2,153
Equity	$-180.5M
Interest Coverage	-0.4
Liabilities	$3B
Long Term Assets	$615.1M
Long Term Liabilities	$2.1B
Net Cash	$-829.9M
Net Cash By Market Cap	$-13.58
Tangible Book Value	$-643.5M
Tangible Book Value Per Share	$-7.76
WACC	6.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.44
Inventory Turnover	10.69
Net Working Capital	$48M
Quick ratio	2.29
Working Capital	$1.3B
Working Capital Turnover	$0.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.66%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	939.35%
1Y total return	80.79%
200-day SMA	67
3Y total return	32.01%
50-day SMA	67.7
50-day SMA vs 200-day SMA	50over200
5Y total return	83.13%
All Time High	87.5
All Time High Change	-15.78%
All Time High Date	2025-11-26
All Time Low	4.03
All Time Low Change	1,728.54%
All Time Low Date	2016-11-03
ATR	3.61
Beta	0.53
Beta1y	0.26
Beta2y	1.1
Ch YTD	-2.99
High	79.91
High52	87.5
High52 Date	2025-11-26
High52ch	-15.78%
Low	69.43
Low52	39.53
Low52 Date	2025-05-08
Low52ch	86.42%
Ma50ch	8.84%
Premarket Change Percent	10.1
Premarket Price	$71
Price vs 200-day SMA	9.99%
RSI	61.33
RSI Monthly	63.07
RSI Weekly	56.24
Sharpe ratio	1.55x
Sortino ratio	2.71
Total Return	-1.66%
Tr YTD	-2.99
Tr1m	5.91%
Tr1w	13.11%
Tr3m	-1.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	15
Analyst Count Top	5
Analyst Price Target Top	$89.4
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.41
Earnings Revenue Estimate	227,520,792x
Earnings Revenue Estimate Growth	-80.65x
Operating Income	$-67.1M
Operating Income Growth Q	-95.27
Operating margin	-8.11
Price target	$84.93
Price Target Change	$15.25
Price Target Change Top	$21.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	73,161,539%
Float Percent	88.2%
Net Borrowing	-1,611,000
Shares Insiders	2.42%
Shares Institutions	106.64%
Shares Out	82,949,338
Shares Qo Q	2.27%
Shares Yo Y	1.66%
Short Float	11.68%
Short Ratio	8.64
Short Shares	10.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-306.2M
Average Volume	1,407,454.95x
Bv Per Share	-2.18
CAPEX	$-8.3M
Ch10y	939.4
Ch1m	5.91
Ch1w	13.11
Ch1y	80.79
Ch3m	-1.33
Ch3y	32.01
Ch5y	83.13
Ch6m	2.66
Change	14.27%
Change From Open	-0.51
Close	64.49
Days Gap	14.86
Depreciation Amortization	47,007,000
Dollar Volume	430,080,557.8
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-67.1M
EBITDA	$-20.1M
EPS	$-2.32
F Score	1
FCF	$-226.3M
FCF EV Yield	-3.26x
FCF Per Share	$-2.73
Financing CF	328,087,000
Fiscal Year End	December
Founded	1,998
Goodwill	82,341,000
Income Tax	$-48.9M
Investing CF	-771,360,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-19
Ma150	71.42
Ma150ch	3.18%
Ma20	69.06
Ma20ch	6.7%
Net CF	-645,427,000
Next Earnings Date	2026-08-06
Open	74.07
Optionable	Yes
Position In Range	40.65
Post Close	73.69
Postmarket Change Percent	-0.01
Postmarket Price	$73.68
Ppne	129,431,000
Pre Close	64.49
Price Date	2026-05-08
Relative Volume	4.15x
Revenue	827,110,000x
SBC By Revenue	9.66x
Share Based Comp	79,908,000
Tax By Revenue	-5.92x
Tr6m	2.66%
Us State	New Jersey
Volume	5,836,349
Z Score	0.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PTCT pay a dividend?

Capital-return profile for this ticker.

Performance

PTCT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PTCT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+106.6%

Float: +88.2% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PTCT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.3

Neutral momentum band

Price vs 200-day MA

+10.0%

50/200-day relationship not available

Beta (5Y)

0.53

Less volatile than the market

Sharpe ratio

1.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PTCT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PTCT stock rating?

PTC Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PTCT analysis?

The full report lives at /stocks/PTCT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PTCT?

The latest report frames PTCT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PTCT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.